DZ Bank
ANAB icon

DZ Bank’s AnaptysBio ANAB Stock Holding History

DZ Bank’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,698
Closed -$385K – 859
2018
Q1 		$385K Buy
+3,698
New +$417K ﹤0.01% 833

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DZ Bank's ANAB Position: Q2 2018 in Review

DZ Bank sold out of AnaptysBio (ANAB) in Q2 2018, closing a stake of 3,698 shares — an estimated $385K sold.

DZ Bank first reported a position in ANAB in Q1 2018 and held it in 1 quarter. The position peaked at $385K in Q1 2018. 124 funds tracked by Wall St. Rank hold ANAB as of Q2 2018.

  • DZ Bank reported no remaining AnaptysBio position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 3,698 AnaptysBio shares in Q2 2018, an estimated $385K.
  • DZ Bank first reported a position in AnaptysBio in Q1 2018 and held it in 1 quarter.
  • DZ Bank's AnaptysBio position peaked at $385K in Q1 2018.
  • 124 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.